February 2022

Rare diseases are often referred to as orphan diseases due to drug companies' disinterest in adopting them to develop treatments. As patient groups are so small, there is often very little incentive for pharma companies to work on new treatments. The same is true for medical devices. We speak to the International Rare Disease Research Consortium about its new working group on MedTech for rare diseases to find out about its goals, the role of medical devices in rare disease diagnostics and care, and the unmet needs and challenges in this area.

3D printing has the potential to revolutionise drug and device manufacturing by allowing products to be printed at healthcare facilities tailored to patients. But the FDA still has some questions around what the regulation would look like for point-of-care manufacturing of medical devices and is currently seeking feedback from healthcare professionals on the matter. We explore how 3D printing could change the game for personalised patient care and the potential safety and regulatory concerns involved.


Editor | Kezia Parkins
Writers | Darcy Jimenez, Abi Millar
Magazine Designer | Tyrrell Lowe

Graphic Designers | Anett Arc, Ashley McPherson, Noemi Balint, Maria Gimenez, Filipe Costa, Martina Labaiova, Will Ingham, Dimeji Akinkuolie

Lead Designer | John Hammond
Publisher | Susanne Hauner

Digital Publishing Director | Duncan West


Sales Manager | Nimai Amin

+44 (0) 207 936 6453

medical Technology is powered by h5mag

read past issues of medical technology HERE

Copyright 2022 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.